Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to assess the effects of transdermal rotigotine on the control
of early morning motor function and sleep disorders compared to placebo in subjects with
idiopathic Parkinsons´s disease. In addition, effects of rotigotine on specific nocturnal and
non-motor symptoms of Parkinson´s disease will be evaluated.